More effective and precise therapies
Imperial College AHSC represents a powerful symbiosis between NHS partners that excel in patient care across a wide range of acute and specialist services, and Imperial College London’s discovery science in biology, engineering, chemistry, physics and data science that has the potential to develop into targeted and cost effective precision medicine treatments.
The AHSC’s confidence in creating new precision treatments is underpinned by a comprehensive infrastructure that supports and facilitates translational research ranging from initial studies in patients through to multi-centre clinical trials.
Its facilities enable investigators to trial exciting new discoveries at the individual and population level and include:
- NIHR Biomedical Research Centres at Imperial College Healthcare NHS Trust and The Royal Marsden NHS Foundation Trust (RMH)
- NIHR Clinical Research Facilities at Imperial, RMH and the Royal Brompton & Harefield NHS Foundation Trust
- NIHR Medical InVitro Diagnostics Collaborative at Imperial
- RMH Clinical Trials Unit and Imperial Clinical Trials Unit
The AHSC’s priorities for Treatment are directed at its Diseases in focus: